# Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

> **NCT04128878** · — · COMPLETED · sponsor: **Samir Saba** · enrollment: 12 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Sotalol
- **DRUG:** Dofetilide

## Key facts

- **NCT ID:** NCT04128878
- **Lead sponsor:** Samir Saba
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04128878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04128878, "Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04128878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*